204 related articles for article (PubMed ID: 16522543)
1. The genetics of the myelodysplastic syndromes: classical cytogenetics and recent molecular insights.
Cherian S; Bagg A
Hematology; 2006 Feb; 11(1):1-13. PubMed ID: 16522543
[TBL] [Abstract][Full Text] [Related]
2. The genetic basis and expanding role of molecular analysis in the diagnosis, prognosis, and therapeutic design for myelodysplastic syndromes.
Nybakken GE; Bagg A
J Mol Diagn; 2014 Mar; 16(2):145-58. PubMed ID: 24457119
[TBL] [Abstract][Full Text] [Related]
3. [Progress of cytogenetic detection in myelodysplastic syndromes].
Zhou QB; Hu XM; Liu -; Ma R
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Dec; 19(6):1536-40. PubMed ID: 22169320
[TBL] [Abstract][Full Text] [Related]
4. [Cytogenetics of myelodysplastic syndromes].
Laï JL; Fenaux P
Pathol Biol (Paris); 1997 Sep; 45(7):550-5. PubMed ID: 9404478
[TBL] [Abstract][Full Text] [Related]
5. Genetic and epigenetic pathways in myelodysplastic syndromes: A brief overview.
Jhanwar SC
Adv Biol Regul; 2015 May; 58():28-37. PubMed ID: 25499150
[TBL] [Abstract][Full Text] [Related]
6. Genetics factors associated with myelodysplastic syndromes.
Macedo LC; Silvestre AP; Rodrigues C; de Alencar JB; Zacarias JM; Ambrosio-Albuquerque EP; Sell AM; Visentainer JE
Blood Cells Mol Dis; 2015 Jun; 55(1):76-81. PubMed ID: 25976472
[TBL] [Abstract][Full Text] [Related]
7. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics.
Mecucci C; Van den Berghe H
Hematol Oncol Clin North Am; 1992 Jun; 6(3):523-41. PubMed ID: 1613004
[TBL] [Abstract][Full Text] [Related]
9. [Diagnosis of MDS: morphology, chromosome abnormalities and genetic mutations].
Hata T
Rinsho Ketsueki; 2015 Oct; 56(10):1978-84. PubMed ID: 26458436
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications.
Panani AD; Roussos C
Cancer Lett; 2006 Apr; 235(2):177-90. PubMed ID: 15935553
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and prognosis in myelodysplastic syndromes. The impact of cytogenetics].
Mecucci C
Recenti Prog Med; 2014 Mar; 105(3):110-4. PubMed ID: 24675452
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic syndromes: review of pathophysiology and current novel treatment approaches.
Warlick ED; Smith BD
Curr Cancer Drug Targets; 2007 Sep; 7(6):541-58. PubMed ID: 17896920
[TBL] [Abstract][Full Text] [Related]
13. Molecular and genetic features of myelodysplastic syndromes.
Greenberg PL
Int J Lab Hematol; 2012 Jun; 34(3):215-22. PubMed ID: 22212119
[TBL] [Abstract][Full Text] [Related]
14. The need for additional genetic markers for myelodysplastic syndrome stratification: what does the future hold for prognostication?
Otrock ZK; Tiu RV; Maciejewski JP; Sekeres MA
Expert Rev Hematol; 2013 Feb; 6(1):59-68. PubMed ID: 23373781
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic features of myelodysplastic syndromes (MDS).
Willman CL
Leukemia; 1998 Sep; 12 Suppl 1():S2-6. PubMed ID: 9777886
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetics in myelodysplastic syndromes.
Haferlach T
Leuk Res; 2012 Dec; 36(12):1459-62. PubMed ID: 22986016
[TBL] [Abstract][Full Text] [Related]
17. Molecular genetic methods in the diagnosis of myelodysplastic syndromes. A review.
Lukackova R; Gerykova Bujalkova M; Majerova L; Mladosievicova B
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):339-45. PubMed ID: 24263214
[TBL] [Abstract][Full Text] [Related]
18. The impact of cytomorphology, cytogenetics, molecular genetics, and immunophenotyping in a comprehensive diagnostic workup of myelodysplastic syndromes.
Bacher U; Haferlach T; Kern W; Weiss T; Schnittger S; Haferlach C
Cancer; 2009 Oct; 115(19):4524-32. PubMed ID: 19569249
[TBL] [Abstract][Full Text] [Related]
19. Somatic mutations and epigenetic abnormalities in myelodysplastic syndromes.
Itzykson R; Kosmider O; Fenaux P
Best Pract Res Clin Haematol; 2013 Dec; 26(4):355-64. PubMed ID: 24507812
[TBL] [Abstract][Full Text] [Related]
20. New strategies in myelodysplastic syndromes: application of molecular diagnostics to clinical practice.
Tothova Z; Steensma DP; Ebert BL
Clin Cancer Res; 2013 Apr; 19(7):1637-43. PubMed ID: 23329810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
